Jaguar Health (JAGX) Cost of Revenue (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Cost of Revenue data on file, last reported at $1.2 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $1.2 million, up 124.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.3 million (up 1193.38% YoY), and the FY2025 annual result was $9.2 million, up 372.38% from the prior year.
• Cost of Revenue retreated to $1.2 million in Q1 2026 per JAGX's latest filing, from $7.7 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $7.7 million in Q4 2025 and troughed at -$5.1 million in Q4 2022.
• A 5-year average of $1.0 million and a median of $1.2 million in 2026 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue tumbled 1181.02% in 2022, then soared 353.51% in 2025.
• A 5-year view of Cost of Revenue shows it stood at -$5.1 million in 2022, then jumped by 113.55% to $687000.0 in 2023, then plunged by 539.88% to -$3.0 million in 2024, then soared by 353.51% to $7.7 million in 2025, then tumbled by 84.88% to $1.2 million in 2026.
• Business Quant data shows JAGX's Cost of Revenue at $1.2 million in Q1 2026, $7.7 million in Q4 2025, and $2.0 million in Q3 2025.